BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27993881)

  • 1. Flow Cytometric Panel-Reactive Antibody Results and the Ability to Find Transfusion-Compatible Platelets after Antibody-Desensitization for Allogeneic Bone Marrow Transplant.
    Rosenbaum ER; Pandey S; Harville TO; Drobena GA; Cottler-Fox M
    Ann Clin Lab Sci; 2016 Dec; 46(6):662-665. PubMed ID: 27993881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
    Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Luminex-based single antigen class II bead assay and its mean fluorescence intensity in renal transplant cases; a retrospective observation in 97 cases.
    Pande A; Pandey P; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
    J Immunoassay Immunochem; 2020 May; 41(3):322-336. PubMed ID: 32122239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Flow Cytometry-Based Method for Detection of Anti-HLA Complement Activating Donor-Specific Antibodies in Renal Transplant Recipients and Its Comparison With Other Conventional Detection Methods.
    Rani L; Singh H; Saikia B; Aggarwal R; Kumar Y; Kumar M; Chhabra S; Kumar M; Kumar B; Kumar V; Das P; Sharma A; Ramchandran R; Kohli HS; Minz RW
    Transplant Proc; 2023; 55(1):134-139. PubMed ID: 36609023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Renal Transplantation Across HLA Barrier: Report from India.
    Aggarwal G; Tiwari AK; Dorwal P; Chauhan R; Arora D; Dara RC; Kher V
    Indian J Nephrol; 2017; 27(3):210-214. PubMed ID: 28553042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different sensitization events on HLA alloimmunization in renal transplant cases; a retrospective observation in 1066 cases.
    Pandey P; Pande A; Mandal S; Devra AK; Sinha VK; Bhatt AP; Mishra S
    Transpl Immunol; 2022 Dec; 75():101680. PubMed ID: 35908630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percent cPRA (Calculated Panel Reactive Antibody) Value Predicts Percent of Positive Platelet Crossmatches.
    Pandey S; Rosenbaum E; Cottler-Fox M; Harville TO
    Ann Clin Lab Sci; 2017 May; 47(3):315-318. PubMed ID: 28667033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of donor-specific HLA antibodies: A retrospective observation in 350 renal transplant cases.
    Pandey P; Pande A; Mandal S; Marik A; Devra AK; Sinha VK; Bhatt AP; Gajway SY; Singh RK; Mishra S; Jha S
    Transpl Immunol; 2023 Apr; 77():101783. PubMed ID: 36608831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantibodies and the outcome of cadaver kidney allografts.
    Vasilescu ER; Ho EK; Colovai AI; Vlad G; Foca-Rodi A; Markowitz GS; D'Agati V; Hardy MA; Ratner LE; Suciu-Foca N
    Hum Immunol; 2006 Aug; 67(8):597-604. PubMed ID: 16916655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul.
    Oguz SR; Sinangil A; Barlas S; Ciftci HS; Ulusoy E; İzgi DK; Ogret Y; Ecder T; Akin B
    Transplant Proc; 2023 Mar; 55(2):303-308. PubMed ID: 36890054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
    Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
    J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of Luminex-crossmatch assay and its mean fluorescence intensity - a retrospective observation in 380 renal transplant cases.
    Pandey P; Pande A; Mishra S; Setya D; Devra AK; Sinha VK; Bhatt AP
    Pol Przegl Chir; 2022 Apr; 94(2):38-48. PubMed ID: 35485317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid flow cytometry assay for HLA antibody detection using a pooled cell panel covering 14 serological crossreacting groups.
    Shroyer TW; Deierhoi MH; Mink CA; Cagle LR; Hudson SL; Rhea SD; Diethelm AG
    Transplantation; 1995 Feb; 59(4):626-30. PubMed ID: 7878769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric platelet cross-matching to predict platelet transfusion in acute leukemia.
    Sayed D; Bakry R; El-Sharkawy N; Zahran A; Khalaf MR
    J Clin Apher; 2011; 26(1):23-8. PubMed ID: 21312256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Sensitive Crossmatch Assays With Donor/Recipient Human Leukocyte Antigen Eplet Matching Predicts Living-Donor Kidney Transplant Outcome.
    Meneghini M; Melilli E; Martorell J; Revuelta I; Rigol-Monzó E; Manonelles A; Montero N; Cucchiari D; Diekmann F; Cruzado JM; Gil-Vernet S; Grinyó JM; Bestard O
    Kidney Int Rep; 2018 Jul; 3(4):926-938. PubMed ID: 29989033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric detection of complement-activating HLA antibodies.
    Schönemann C; Lachmann N; Kiesewetter H; Salama A
    Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.